Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?

COVID-19 anti-SARS-CoV-2 antibodies booster mRNA-1273 vaccine peritoneal dialysis spikevax

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 27 03 2022
accepted: 23 05 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

In dialysis patients the humoral response to anti-SARS-CoV-2 vaccines is attenuated and rapidly declines over time. However, data on the persistence of the immune response in peritoneal dialysis (PD) patients are scarce, particularly after a third (booster) dose with mRNA-1273 vaccine. In this prospective cohort study, we report anti-SARS-CoV-2 antibody levels in PD patients before and after the third dose of mRNA-1273 vaccine. Six months after the second dose, anti-SARS-CoV-2 antibodies were detected in all patients (

Identifiants

pubmed: 35814775
doi: 10.3389/fmed.2022.905798
pmc: PMC9263093
doi:

Types de publication

Journal Article

Langues

eng

Pagination

905798

Informations de copyright

Copyright © 2022 Beilhack, Monteforte, Frommlet, Reindl-Schwaighofer, Strassl and Vychytil.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

N Engl J Med. 2021 Dec 9;385(24):e83
pubmed: 34614327
Clin Kidney J. 2021 Aug 13;14(11):2349-2355
pubmed: 34754430
Vaccine. 2022 Jan 21;40(2):306-315
pubmed: 34933765
Kidney Int Rep. 2021 Sep;6(9):2292-2304
pubmed: 34250319
J Clin Med. 2021 Dec 23;11(1):
pubmed: 35011801
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Am J Kidney Dis. 2022 Feb;79(2):307-310
pubmed: 34758369
J Clin Med. 2021 Oct 30;10(21):
pubmed: 34768631
Nephrol Dial Transplant. 2002 Jun;17(6):1085-92
pubmed: 12032201
Kidney Int. 2022 Feb;101(2):390-402
pubmed: 34856313
Front Immunol. 2021 Dec 02;12:780594
pubmed: 34925359
Clin Kidney J. 2021 Dec 27;15(3):527-533
pubmed: 35198159
Kidney Int. 2021 Dec;100(6):1334-1335
pubmed: 34656642
Biochem Biophys Res Commun. 2021 Jan 29;538:192-203
pubmed: 33069360
Diabetes Obes Metab. 2022 May;24(5):849-858
pubmed: 34984802
Am J Kidney Dis. 2022 Feb;79(2):185-192.e1
pubmed: 34508833
Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33
pubmed: 18701615
Clin Kidney J. 2021 Jul 06;14(10):2266-2267
pubmed: 34603705

Auteurs

Georg Beilhack (G)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Rossella Monteforte (R)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Florian Frommlet (F)

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Roman Reindl-Schwaighofer (R)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Robert Strassl (R)

Division of Clinical Virology, Medical University of Vienna, Vienna, Austria.

Andreas Vychytil (A)

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Classifications MeSH